BOGDAN RISTIC: Open Payments
NPI 1609463538 · HERCULES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 17 payments from 9 companies in 2025. Trend: 2023 $166 · 2024 $605 · 2025 $550
Food & beverage: $450Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $146 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $126 |
| ABBVIE INC. | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Janssen Biotech, Inc. | 1 | $34 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $26 |
| LEO Pharma Inc. | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, SPEVIGO, TREMFYA, ILUMYA, ADBRY, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
